Stocktoria
U S PHYSICAL THERAPY INC /NV USPH
NYSE · stock · Services-Health Services · website · IPO 1992-05-29
U S PHYSICAL THERAPY INC /NV financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $781.0M | $671.3M | $604.8M | $553.1M | $495.0M | $423.0M | $482.0M | $453.9M | $414.1M | $356.5M |
| Gross profit | $149.7M | $123.9M | $121.5M | $112.0M | $117.2M | $94.5M | $112.5M | $101.7M | $90.6M | $82.0M |
| SG&A expense | $69.3M | $58.3M | $52.0M | $46.1M | $46.5M | $42.0M | $45.0M | $41.3M | $35.9M | $32.5M |
| Operating income | $86.7M | $63.0M | $50.5M | $56.8M | $70.6M | $52.4M | $67.4M | $60.3M | $54.7M | $49.5M |
| Interest expense | — | — | — | — | — | — | $2.1M | $2.0M | $21.1M | $11.5M |
| Income tax | $19.8M | $14.6M | $12.2M | $12.2M | $15.3M | $13.0M | $13.6M | $11.4M | $6.0M | $11.9M |
| Net income | $39.6M | $31.4M | $28.2M | $32.2M | $40.8M | $35.2M | $40.0M | $34.9M | $22.3M | $20.6M |
| EPS (diluted) | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 | $2.48 | $2.45 | — | — | — |
| Operating cash flow | $75.1M | $74.9M | $82.0M | $58.5M | $76.4M | $100.0M | $62.4M | $73.0M | $56.5M | $51.0M |
| Cash & equivalents | $35.6M | $41.4M | $152.8M | $31.6M | $28.6M | $32.9M | $23.5M | $23.4M | $21.9M | $20.0M |
| Total assets | $1.2B | $1.2B | $997.2M | $858.2M | $749.4M | $594.4M | $630.5M | $443.2M | $419.0M | $351.2M |
| Total liabilities | $433.8M | $408.4M | $345.0M | $373.6M | $297.0M | $184.4M | $181.4M | $92.3M | $110.3M | $162.5M |
| Shareholders' equity | $476.9M | $490.0M | $477.4M | $317.1M | $297.2M | $277.6M | $241.7M | $216.9M | $206.1M | $188.7M |
Growth · year-over-year · Revenue CAGR 9.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +16.3% | +11.0% | +9.3% | +11.7% | +17.0% | -12.2% | +6.2% | +9.6% | +16.1% | +7.6% |
| Net income growth | +26.0% | +11.3% | -12.2% | -21.2% | +16.0% | -12.1% | +14.8% | +56.7% | +8.3% | -0.3% |
| EPS growth | -22.8% | +43.8% | -43.1% | -6.6% | -2.8% | +1.2% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.